secwatch.observer — SEC 8-K summary
======================================

Issuer:     Fortress Biotech, Inc. (FBIO)
CIK:        0001429260
Form:       8-K
Filed at:   2025-06-23T23:59:59+00:00
Accession:  0001558370-25-008787
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Fortress Biotech stockholders elect seven directors, approve charter amendment at 2025 annual meeting
--------------------------------------------------------------------------------

- All seven director nominees elected: Rosenwald, Harvey, Hoenlein, Klein, Lobell, Lorenz, Weiss.
- Ratification of KPMG LLP as independent auditor for FY2025 approved: 20,400,173 for, 314,490 against.
- Advisory vote on executive compensation passed: 9,388,005 for, 312,265 against, 10,917,039 broker non-votes.
- Board sets say-on-pay frequency every three years until 2031; vote: 2,051,405 for one year, 7,421,176 for three years.
- Charter amendment for officer exculpation approved: 7,964,484 for, 1,723,623 against, 10,917,039 broker non-votes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1429260/000155837025008787/0001558370-25-008787-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1429260/000155837025008787/fbio-20250617x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-25-008787

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer